Corticolimbic dysregulation and chronic methamphetamine abuse

Addiction

Volumn 102, Issue SUPPL. 1, 2007, Pages 5-15

  Baicy, Kate ^b,c   London, Edythe D ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain imaging; Cognition; Emotion; Inhibitory control; Methamphetamine

Indexed keywords

METHAMPHETAMINE;

ABSTINENCE; BEHAVIOR CONTROL; BEHAVIOR MODIFICATION; BEHAVIOR THERAPY; BRAIN CORTEX; BRAIN DISEASE; BRAIN FUNCTION; CHRONIC DRUG ADMINISTRATION; CLINICAL RESEARCH; COGNITIVE DEFECT; DOPAMINERGIC NERVE CELL; DRUG ABUSE; DRUG DEPENDENCE; GLUCOSE METABOLISM; GRAY MATTER; HUMAN; IMAGE ANALYSIS; LIMBIC CORTEX; NEUROIMAGING; REVIEW; SEROTONINERGIC NERVE CELL;

AMPHETAMINE-RELATED DISORDERS; BRAIN DISEASES; COGNITION DISORDERS; COGNITIVE THERAPY; EMOTIONS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHAMPHETAMINE;

EID: 33847297995     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2006.01777.x     Document Type: Review

References (125)

1. Varner K. J., Ogden B. A., Delcarpio J., Meleg-Smith S. Cardiovascular responses elicited by the 'binge' administration of methamphetamine. J Pharmacol Exp Ther 2002; 301: 152-9.
2. Brown P. L., Wise R. A., Kiyatkin E. A. Brain hyperthermia is induced by methamphetamine and exacerbated by social interaction. J Neurosci 2003; 23: 3924-9.
3. Davidson C., Gow A. J., Lee T. H., Ellinwood E. H. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res Brain Res Rev 2001; 36: 1-22.
4. Kogan F. J., Nichols W. K., Gibb J. W. Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels. Eur J Pharmacol 1976; 36: 363-71.
5. Kokoshka J. M., Vaughan R. A., Hanson G. R., Fleckenstein A. E. Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters. Eur J Pharmacol 1998; 361: 269-75.
6. 11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations. J Neurosci 1998; 18: 419-27.
7. McCann U. D., Ricaurte G. A. Amphetamine neurotoxicity: accomplishments and remaining challenges. Neurosci Biobehav Rev 2004; 27: 821-6.
8. Wilson J. M., Kalasinsky K. S., Levey A. I., Bergeron C., Reiber G., Anthony R. M. et al. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med 1996; 2: 699-703.
9. McCann U. D., Wong D. F., Yokoi F., Villemagne V., Dannals R. F., Ricaurte G. A. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. J Neurosci 1998; 18: 8417-22.
10. Sekine Y., Iyo M., Ouchi Y., Matsunaga T., Tsukada H., Okada H. et al. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am J Psychiatry 2001; 158: 1206-14.
11. Volkow N. D., Chang L., Wang G. J., Fowler J. S., Leonido-Yee M., Franceschi D. et al. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 2001; 158: 377-82.
12. Sekine Y., Minabe Y., Ouchi Y., Takei N., Iyo M., Nakamura K. et al. Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. Am J Psychiatry 2003; 160: 1699-701.
13. Volkow N. D., Chang L., Wang G. J., Fowler J. S., Ding Y. S., Sedler M. et al. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 2001; 158: 2015-21.
14. London E. D., Simon S. L., Berman S. M., Mandelkern M. A., Lichtman A. M., Bramen J. et al. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry 2004; 61: 73-84.
15. Volkow N. D., Chang L., Wang G. J., Fowler J. S., Franceschi D., Sedler M. J. et al. Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. Am J Psychiatry 2001; 158: 383-9.
16. Wang G. J., Volkow N. D., Chang L., Miller E., Sedler M., Hitzemann R. et al. Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. Am J Psychiatry 2004; 161: 242-8.
17. US Department of Health and Human Services. Treatment for Stimulant Use Disorders. DHHS Publication (SMA). Rockville, MD: US Department of Health and Human Services, Public Health Service, Substance Abuse and Mental Health Administration; 1999.
18. Brecht M. L., von Mayrhauser C., Anglin M. D. Predictors of relapse after treatment for methamphetamine use. J Psychoact Drugs 2000; 32: 211-20.
19. Zweben J. E., Cohen J. B., Christian D., Galloway G. P., Salinardi M., Parent D. et al. Psychiatric symptoms in methamphetamine users. Am J Addict 2004; 13: 181-90.
20. Hodgins D. C., el-Guebaly N., Armstrong S. Prospective and retrospective reports of mood states before relapse to substance use. J Consult Clin Psychol 1995; 63: 400-7.
21. Baicy K., Bearden C. E., Monterosso J., Brody A. L., Isaacson A. J., London E. D. Common substrates of dysphoria in stimulant drug abuse and primary depression: therapeutic targets. Int Rev Neurobiol 2005; 65: 117-45.
22. Kilbey M. M., Breslau N., Andreski P. Cocaine use and dependence in young adults: associated psychiatric disorders and personality traits. Drug Alcohol Depend 1992; 29: 283-90.
23. Gawin F. H., Kleber H. D. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations. Arch Gen Psychiatry 1986; 43: 107-13.
24. Drevets W. C. Neuroimaging abnormalities in the amygdala in mood disorders. Ann NY Acad Sci 2003; 985: 420-44.
25. Brothers L. Neurophysiology of the Perception of Intentions by Primates. Cambridge, MA: MIT Press; 1995.
26. Rubin R. T., Mandell A. J., Crandall P. H. Corticosteroid responses to limbic stimulation in man: localization of stimulus sites. Science 1966; 153: 767-8.
27. Gloor P. The role of the limbic system in experiential phenomena of temporal lobe epilepsy. Ann Neurol 1982; 12: 129-44.
28. Davis M., Whalen P. J. The amygdala: vigilance and emotion. Mol Psychiatry 2001; 6: 13-34.
29. Drevets W. C. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol 2001; 11: 240-9.
30. Childress A. R., Mozley P. D., McElgin W., Fitzgerald J., Reivich M., O'Brien C. P. Limbic activation during cue-induced cocaine craving. Am J Psychiatry 1999; 156: 11-8.
31. Grant S., London E. D., Newlin D. B., Villemagne V. L., Liu X., Contoreggi C. et al. Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci USA 1996; 93: 12040-5.
32. London E. D., Ernst M., Grant S., Bonson K., Weinstein A. Orbitofrontal cortex and human drug abuse: functional imaging. Cereb Cortex 2000; 10: 334-42.
33. Wang G. J., Volkow N. D., Fowler J. S., Cervany P., Hitzemann R. J., Pappas N. R. et al. Regional brain metabolic activation during craving elicited by recall of previous drug experiences. Life Sci 1999; 64: 775-84.
34. Wexler B. E., Gottschalk C. H., Fulbright R. K., Prohovnik I., Lacadie C. M., Rounsaville B. J. et al. Functional magnetic resonance imaging of cocaine craving. Am J Psychiatry 2001; 158: 86-95.
35. Bonson K. R., Grant S. J., Contoreggi C. S., Links J. M., Metcalfe J., Weyl H. L. et al. Neural systems and cue-induced cocaine craving. Neuropsychopharmacology 2002; 26: 376-86.
36. Breiter H. C., Gollub R. L., Weisskoff R. M., Kennedy D. N., Makris N., Berke J. D. et al. Acute effects of cocaine on human brain activity and emotion. Neuron 1997; 19: 591-611.
37. Hiroi N., White N. M. The lateral nucleus of the amygdala mediates expression of the amphetamine-produced conditioned place preference. J Neurosci 1991; 11: 2107-16.
38. Brown E. E., Figiber H. C. Differential effects of excitotoxic lesions of the amygdala on cocaine-induced conditioned locomotion and conditioned place preference. Psychopharmacology (Berl) 1993; 113: 123-30.
39. Etkin A., Egner T., Peraza D. M., Kandel E. R., Hirsch J. Resolving emotional conflic: a role for the rostral anterior cingulate cortex in modulating activity in the amygdala. Neuron 2006; 51: 871-82.
40. Thompson P. M., Hayashi K. M., Simon S. L., Geaga J. A., Hong M. S., Sui Y. et al. Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci 2004; 24: 6028-36.
41. Chang L., Ernst T., Speck O., Patel H., De Silva M., Leonido-Yee M. et al. Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users. Psychiatry Res 2002; 114: 65-79.
42. 99MTc-HMPAO and SPECT. Prog Neuropsychopharmacol Biol Psychiatry 1997; 21: 789-96.
43. Critchley H. D. Neural mechanisms of autonomic, affective, and cognitive integration. J Comp Neurol 2005; 493: 154-66.
44. Critchley H. D., Wiens S., Rotshtein P., Ohman A., Dolan R. J. Neural systems supporting interoceptive awareness. Nat Neurosci 2004; 7: 189-95.
45. Berman S. M., Voytek B., Mandelkern M., Hassid B. D., Monterosso J. R., Miotto K. et al. Changes in cerebral glucose metabolism during the first month of abstinence from chronic methamphetamine abuse. Soc Neurosci Abstract 2006.
46. Perez J. A. Jr, Arsura E. L., Strategos S. Methamphetamine-related stroke: four cases. J Emerg Med 1999; 17: 469-71.
47. Rothrock J. F., Rubenstein R., Lyden P. D. Ischemic stroke associated with methamphetamine inhalation. Neurology 1988; 38: 589-92.
48. Yen D. J., Wang S. J., Ju T. H., Chen C. C., Liao K. K., Fuh J. L. et al. Stroke associated with methamphetamine inhalation. Eur Neurol 1994; 34: 16-22.
49. Jernigan T. L., Gamst A. C., Archibald S. L., Fennema-Notestine C., Mindt M. R., Marcotte T. D. et al. Effects of methamphetamine dependence and HIV infection on cerebral morphology. Am J Psychiatry 2005; 162: 1461-72.
50. Ernst T., Chang L., Leonido-Yee M., Speck O. Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study. Neurology 2000; 54: 1344-9.
51. Nordahl T. E., Salo R., Possin K., Gibson D. R., Flynn N., Leamon M. et al. Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: a preliminary proton MRS study. Magnetic resonance spectroscopy. Psychiatry Res 2002; 116: 43-52.
52. Sekine Y., Minabe Y., Kawai M., Suzuki K., Iyo M., Isoda H. et al. Metabolite alterations in basal ganglia associated with methamphetamine-related psychiatric symptoms. A Proton MRS Study. Neuropsychopharmacology 2002; 27: 453-61.
53. Ernst T., Chang L., Leonida-Yee M., Speck O. Evidence for long term neurotoxicity associated with methamphetamine abuse: A 1 H MRS study. Neurology 2000; 54(6): 1344-9.
54. Nordahl T. E., Salo R., Leamon M. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review. J Neuropsychiatry Clin Neurosci 2003; 15: 317-25.
55. Kalechstein A. D., Newton T. F., Green M. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. J Neuropsychiatry Clin Neurosci 2003; 15: 215-20.
56. Simon S. L., Domier C., Carnell J., Brethen P., Rawson R., Ling W. Cognitive impairment in individuals currently using methamphetamine. Am J Addict 2000; 9: 222-31.
57. Woods S. P., Rippeth J. D., Conover E., Gongvatana A., Gonzalez R., Carey C. L. et al. Deficient strategic control of verbal encoding and retrieval in individuals with methamphetamine dependence. Neuropsychology 2005; 19: 35-43.
58. Simon S. L., Domier C. P., Sim T., Richardson K., Rawson R. A., Ling W. Cognitive performance of current methamphetamine and cocaine abusers. J Addict Dis 2002; 21: 61-74.
59. Rawson R. A., Gonzales R., Brethen P. Treatment of methamphetamine use disorders: an update. J Subst Abuse Treat 2002; 23: 145-50.
60. Carroll K. Therapy Manuals for Drug Abuse. Manual 1. A Cognitive Behavioral Approach: Treating Cocaine Addiction. NIH Publication no. 98-4308. Bethesda, MD: National Institute on Drug Abuse; 1998.
61. Maude-Griffin P. M., Hohenstein J. M., Humfleet G. L., Reilly P. M., Tusel D. J., Hall S. M. Superior efficacy of cognitive-behavioral therapy for urban crack cocaine abusers: main and matching effects. J Consult Clin Psychol 1998; 66: 832-7.
62. Friedman N. P., Miyake A. The relations among inhibition and interference control functions: a latent-variable analysis. J Exp Psychol Gen 2004; 133: 101-35.
63. Bechara A., Tranel D., Damasio H. Characterization of the decision-making deficit of patients with ventromedial prefrontal cortex lesions. Brain 2000; 123: 2189-202.
64. Fillmore M. T., Rush C. R. Impaired inhibitory control of behavior in chronic cocaine users. Drug Alcohol Depend 2002; 66: 265-73.
65. Jentsch J. D., Taylor J. R. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl) 1999; 146: 373-90.
66. Volkow N. D., Li T. K. Drug addiction: the neurobiology of behaviour gone awry. Nat Rev Neurosci 2004; 5: 963-70.
67. Kok A. Varieties of inhibition. manifestations in cognition, event-related potentials and aging. Acta Psychol 1999; 101: 129-58.
68. Logan G. D., Schachar R. J., Tannock R. Impulsivity and inhibitory control. Psychol Sci 1997; 8:.
69. Logan G. D., Cowan W. B., Davis K. A. On the ability to inhibit simple and choice reaction time responses: a model and a method. J Exp Psychol Hum Percept Perform 1984; 10: 276-91.
70. Jentsch J. D., Olausson P., De La Garza R. II, Taylor J. R. Impairments of reversal learning and response perseveration after repeated, intermittent cocaine administrations to monkeys. Neuropsychopharmacology 2002; 26: 183-90.
71. Richards J. B., Sabol K. E., de Wit H. Effects of methamphetamine on the adjusting amount procedure, a model of impulsive behavior in rats. Psychopharmacology (Berl) 1999; 146: 432-9.
72. Monterosso J. R., Aron A. R., Cordova X., Xu J., London E. D. Deficits in response inhibition associated with chronic methamphetamine abuse. Drug Alcohol Depend 2005; 79: 273-7.
73. Nigg J. T. Is ADHD a disinhibitory disorder? Psychol Bull 2001; 127: 571-98.
74. Aron A. R., Robbins T. W., Poldrack R. A. Inhibition and the right inferior frontal cortex. Trends Cogn Sci 2004; 8: 170-7.
75. Aron A. R., Poldrack R. A. Cortical and subcortical contributions to Stop Signal response inhibition: role of the subthalamic nucleus. J Neurosci 2006; 26: 2424-33.
76. Stroop J. R. Studies of interference in serial verbal reactions. J Exp Psychol 1935; 18: 634-62.
77. Salo R., Nordahl T. E., Possin K., Leamon M., Gibson D. R., Galloway G. P. et al. Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals. Psychiatry Res 2002; 111: 65-74.
78. Di Sclafani V., Tolou-Shams M., Price L. J., Fein G. Neuropsychological performance of individuals dependent on crack-cocaine, or crack-cocaine and alcohol, at 6 weeks and 6 months of abstinence. Drug Alcohol Depend 2002; 66: 161-71.
79. Verdejo-Garcia A. J., Lopez-Torrecillas F., Aguilar de Arcos F., Perez-Garcia M. Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis. Addict Behav 2005; 30: 89-101.
80. Bolla K. I., Rothman R., Cadet J. L. Dose-related neurobehavioral effects of chronic cocaine use. J Neuropsychiatry Clin Neurosci 1999; 11: 361-9.
81. Salo R., Nordahl T. E., Moore C., Waters C., Natsuaki Y., Galloway G. P. et al. A dissociation in attentional control: evidence from methamphetamine dependence. Biol Psychiatry 2005; 57: 310-3.
82. Taylor S. F., Kornblum S., Lauber E. J., Minoshima S., Koeppe R. A. Isolation of specific interference processing in the Stroop task: PET activation studies. Neuroimage 1997; 6: 81-92.
83. Pardo J. V., Pardo P. J., Janer K. W., Raichle M. E. The anterior cingulate cortex mediates processing selection in the Stroop attentional conflict paradigm. Proc Natl Acad Sci USA 1990; 87: 256-9.
84. Milham M. P., Banich M. T. Anterior cingulate cortex: an fMRI analysis of conflict specificity and functional differentiation. Hum Brain Mapp 2005; 25: 328-35.
85. Mead L. A., Mayer A. R., Bobholz J. A., Woodley S. J., Cunningham J. M., Hammeke T. A. et al. Neural basis of the Stroop interference task: response competition or selective attention? J Int Neuropsychol Soc 2002; 8: 735-42.
86. Gruber S. A., Rogowska J., Holcomb P., Soraci S., Yurgelun-Todd D. Stroop performance in normal control subjects: an fMRI study. Neuroimage 2002; 16: 349-60.
87. 15O PET study of Stroop task performance. Neuroimage 1995; 2: 264-72.
88. Brown G. G., Kindermann S. S., Siegle G. J., Granholm E., Wong E. C., Buxton R. B. Brain activation and pupil response during covert performance of the Stroop Color Word task. J Int Neuropsychol Soc 1999; 5: 308-19.
89. Bench C. J., Frith C. D., Grasby P. M., Friston K. J., Paulesu E., Frackowiak R. S. et al. Investigations of the functional anatomy of attention using the Stroop test. Neuropsychologia 1993; 31: 907-22.
90. Banich M. T., Milham M. P., Atchley R. A., Cohen N. J., Webb A., Wszalek T. et al. Prefrontal regions play a predominant role in imposing an attentional 'set': evidence from fMRI. Brain Res Cogn Brain Res 2000; 10: 1-9.
91. Yantis S., Serences J. T. Cortical mechanisms of space-based and object-based attentional control. Curr Opin Neurobiol 2003; 13: 187-93.
92. London E. D., Berman S. M., Voytek B., Simon S. L., Mandelkern M. A., Monterosso J. et al. Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers. Biol Psychiatry 2005; 58: 770-8.
93. Bechara A. Disturbances of emotion regulation after focal brain lesions. Int Rev Neurobiol 2004; 62: 159-93.
94. Bechara A., Damasio H. Decision-making and addiction (part I): impaired activation of somatic states in substance dependent individuals when pondering decisions with negative future consequences. Neuropsychologia 2002; 40: 1675-89.
95. Phan K. L., Wager T. D., Taylor S. F., Liberzon I. Functional neuroimaging studies of human emotions. CNS Spectr 2004; 9: 258-66.
96. Sprengelmeyer R., Rausch M., Eysel U. T., Przuntek H. Neural structures associated with recognition of facial expressions of basic emotions. Proc Biol Sci 1998; 265: 1927-31.
97. Damasio A. R. The somatic marker hypothesis and the possible functions of the prefrontal cortex. Philos Trans R Soc Lond B Biol Sci 1996; 351: 1413-20.
98. Payer D., Albistegui-Dubois R., Xu J., Monterosso J. R., Fong T., Cohen M. S., London E. D. Deficits in Cortical Activation Associated with Emotion Processing in Methamphetamine Abusers. Washington DC: Society for Neuroscience; 2005.
99. Rosenkranz J. A., Moore H., Grace A. A. The prefrontal cortex regulates lateral amygdala neuronal plasticity and responses to previously conditioned stimuli. J Neurosci 2003; 23: 11054-64.
100. Quirk G. J., Likhtik E., Pelletier J. G., Pare D. Stimulation of medial prefrontal cortex decreases the responsiveness of central amygdala output neurons. J Neurosci 2003; 23: 8800-7.
101. Milad M. R., Vidal-Gonzalez I., Quirk G. J. Electrical stimulation of medial prefrontal cortex reduces conditioned fear in a temporally specific manner. Behav Neurosci 2004; 118: 389-94.
102. Hariri A. R., Bookheimer S. Y., Mazziotta J. C. Modulating emotional responses: effects of a neocortical network on the limbic system. Neuroreport 2000; 11: 43-8.
103. Lieberman M. D., Hariri A., Jarcho J. M., Eisenberger N. I., Bookheimer S. Y. An fMRI investigation of race-related amygdala activity in African-American and Caucasian-American individuals. Nat Neurosci 2005; 8: 720-2.
104. Ochsner K. N., Bunge S. A., Gross J. J., Gabrieli J. D. Rethinking feelings: an FMRI study of the cognitive regulation of emotion. J Cogn Neurosci 2002; 14: 1215-29.
105. Phan K. L., Fitzgerald D. A., Nathan P. J., Moore G. J., Uhde T. W., Tancer M. E. Neural substrates for voluntary suppression of negative affect: a functional magnetic resonance imaging study. Biol Psychiatry 2005; 57: 210-9.
106. Levesque J., Eugene F., Joanette Y., Paquette V., Mensour B., Beaudoin G. et al. Neural circuitry underlying voluntary suppression of sadness. Biol Psychiatry 2003; 53: 502-10.
107. Beauregard M., Levesque J., Bourgouin P. Neural correlates of conscious self-regulation of emotion. J Neurosci 2001; 21: RC165.
108. Schaefer S. M., Jackson D. C., Davidson R. J., Aguirre G. K., Kimberg D. Y., Thompson-Schill S. L. Modulation of amygdalar activity by the conscious regulation of negative emotion. J Cogn Neurosci 2002; 14: 913-21.
109. Goeders N. E. The impact of stress on addiction. Eur Neuropsychopharmacol 2003; 13: 435-41.
110. Lang P. J., Bradley M. M., Cuthbert B. N. International affective picture system (IAPS): affective ratings of pictures and instruction manual. Gainesville, FL: University of Florida; 2005.
111. Baicy K. M. Monterosso J. R. London E. D. Methamphetamine Dependence and Deficient Regulation of Negative Emotion. Atlanta, GA: Society for Neuroscience; 2006.
112. Quirk G. J. Gehlert D. R. Inhibition of the amygdala: key to pathological states? Ann NY Acad Sci 2003; 985: 263-72.
113. Grace A. A. Rosenkranz J. A. Regulation of conditioned responses of basolateral amygdala neurons. Physiol Behav 2002; 77: 489-93.
114. Goldstein R. Z. Volkow N. D. Drug addiction and its underlying neurobiological basis. neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 2002; 159: 1642-52.
115. Cohen J. B. Dickow A. Horner K. Zweben J. E. Balabis J. Vandersloot D. et al. Abuse and violence history of men and women in treatment for methamphetamine dependence. Am J Addict 2003; 12: 377-85.
116. Boles S., Miotto K. Substance abuse and violence: a review of the literature. Aggression Violent Behav 2003; 8: 155-74.
117. Davidson R. J., Putnam K. M., Larson C. L. Dysfunction in the neural circuitry of emotion regulation - a possible prelude to violence. Science 2000; 289: 591-4.
118. Miller W. R. What is a relapse? Fifty ways to leave the wagon. Addiction 1996; 91: S15-27.
119. Paulus M. P., Tapert S. F., Schuckit M. A. Neural activation patterns of methamphetamine-dependent subjects during decision making predict relapse. Arch Gen Psychiatry 2005; 62: 761-8.
120. Bastuji H., Jouvet M. Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil. Prog Neuropsychopharmacol Biol Psychiatry 1988; 12: 695-700.
121. Bastuji H., Jouvet M. Treatment of hypersomnia with modafinil. Presse Med 1986; 15: 1330-1.
122. Turner D. C., Robbins T. W., Clark L., Aron A. R., Dowson J., Sahakian B. J. Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl) 2003; 165: 260-9.
123. Turner D. C., Clark L., Dowson J., Robbins T. W., Sahakian B. J. Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder. Biol Psychiatry 2004; 55: 1031-40.
124. Turner D. C., Clark L., Pomarol-Clotet E., McKenna P., Robbins T. W., Sahakian B. J. Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia. Neuropsychopharmacology 2004; 29: 1363-73.
125. Dackis C. A., Kampman K. M., Lynch K. G., Pettinati H. M., O'Brien C. P. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 2005; 30: 205-11.